Cold Chain Investment for Process Efficiencies

? In recent study conducted by the U.K.-based Medicines and Healthcare Products Regulatory Agency (MHRA), a staggering 43% of critical and major product deficiencies are related to ineffective temperature control and monitoring during storage and transportation. ? The World Health Organization (WHO) recently maintained that 25% of all vaccine products arrive at their final destination in a degraded state. ? Cold Chain logistics technology is still evolving and need to be efficient to meet this demand generated by the sales of large molecule drugs by 2015. This whitepaper will focus on problems encountered by Pharma companies and emerging solutions and their drivers in this space.